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ABSTRACT
One important goal of genomics is to explore the
extent of alternative splicing in the transcriptome
and generate a comprehensive catalog of splice
forms. New computational and experimental
approaches have led to an increase in the
number of predicted alternatively spliced tran-
scripts; however, validation of these predictions
has not kept pace. In this work, we systematically
explore different methods for the validation of
cassette exons predicted by computational meth-
ods or tiling microarrays. Our goal was to find a
procedure that is cost effective, sensitive and
specific. We examined three ways of priming the
reverse transcription (RT) reaction—poly-dT prim-
ing, random priming and pooled exon-specific
priming. We also examined two strategies for
PCR amplification—flanking PCR, which uses pri-
mers that hybridize to the constitutive exons
flanking the predicted exon, and a semi-nested
PCR with a primer that targets the predicted exon.
We found that the combination of RT using a pool
of gene-specific primers followed by semi-nested
PCR resulted in a significant increase in sensitivity
over the most commonly used methodology (97%
of the test set was detected versus 14%). Our
method was also highly specific—no false posi-
tives were detected using a test set of true
negatives. Finally, we demonstrate that this
method is able to detect alternative exons with a
high sensitivity from whole-organism RNA, allow-
ing all tissues to be sampled in a single experi-
ment. The protocol developed here is an accurate
and cost-effective way to validate predictions of
alternative splicing.
INTRODUCTION
Alternative splicing is an important cellular phenomenon
that has been connected with a number of physiological
and pathophysiological processes (1,2). It is estimated that
 74% of human protein coding genes are alternatively
spliced (3). However, the detection of alternative splice
variants is often challenging because, unlike constitutive
splicing events, alternatively spliced exons often exhibit
environmental, temporal or cell-type speciﬁc expression
patterns. Most of the known alternative exons were
discovered by sequencing large expressed sequence tag
(EST) libraries. However, despite millions of available
ESTs, the coverage of many organisms’ transcriptome
remains incomplete due to issues such as transcript end
bias, library coverage limitations and sampling diﬀerences
(4). To address these issues, new technologies to detect
alternative splicing of mRNA are being developed. For
example, splice junction micro-arrays have been designed
to detect changes at the exon splice junctions of a large
number of known genes (3). Whole genome tiling array
(WGTA) analysis has been able to provide even more
detail by using overlapping oligonucleotide probes to
detect exons from whole sequenced genomes (5).
Complementing these new experimental approaches, are
computational algorithms designed to detect novel alter-
native exons from genomic sequences without relying on
EST evidence (6–8). These new approaches often yield a
large number of putative alternative splicing events.
However, the speciﬁcity of these approaches is still
relatively low compared with EST sequencing (9), and so
these candidates must be validated experimentally. This
crucial experimental step has become the bottleneck in
discovering new alternatively spliced isoforms, so we
sought to optimize this procedure, focusing on methods to
validate cassette exons.
Validation of cassette exons is typically achieved in
three steps: (i) perform reverse transcription (RT) of the
RNA samples, (ii) perform the polymerase chain reaction
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and sequence the products to distinguish true splice
variants from false positives. Each step can be carried
out in diﬀerent ways. For example, there are three ways to
prime the RT reaction: poly-T priming, random priming
and gene-speciﬁc priming. Alternatively, the PCR can be
performed using primers that target the constitutive exons
that ﬂank the predicted splicing event or, in a semi-nested
format, using a primer that targets the predicted exon.
Currently there is no clear consensus to the optimal
approach to use in splice variant validation. Most studies
use poly-T priming for the RT reactions followed by
ﬂanking PCR (3,6–8), despite the fact that neither the
sensitivity nor the speciﬁcity of this procedure has been
characterized. Our goal was to develop a cost-eﬀective
approach that is sensitive, speciﬁc and allows for a large
number of tissues to be analyzed. Therefore, we carried
out a systematic survey to assess three diﬀerent priming
methods for the RT reaction and two diﬀerent PCR
methods. We measured their ability to detect a set of
known alternative exons in a pooled sample containing
RNA from 18 tissues. We also assessed the false positive
rate of these methods using a set of pseudo-exons—
intronic sequences that are not spliced but have donor and
acceptor sites (10). Our results showed that there are
signiﬁcant diﬀerences in sensitivity between the diﬀerent
types of RT priming. In addition, we demonstrated that a
semi-nested PCR approach is signiﬁcantly more sensitive
than the conventional ﬂanking PCR approach utilized in
most studies.
MATERIALS AND METHODS
Positive and negativecontrol test sets
A set of 48 EST annotated alternatively spliced cassette
exons were selected from the Alternative Splicing
Database, splicing event annotations ﬁle (11) based on
varying frequencies of exon inclusion (6–97%) into the
canonical transcript (Supplementary Table A). Another
set of 24 pseudo exons were used as negative controls for
the semi-nested RT-PCR experiments. These pseudo
exons were selected by randomly picking pairs of AG
(Adenine-Guanine) acceptor and GT (Guanine-Thymine)
donor dinucleotide sites from the introns of randomly
selected RefSeq genes. We required these exons to be read
through, thus preserving the reading frame and lacking
any non-sense codons. We also compared these pseudo
exons with the EST data to make sure that there was no
evidence of this sequence being incorporated as part of a
transcript. Speciﬁcally, we required that the pseudo-exon
sequence was not present in any EST transcripts, while the
ﬂanking constitutive exon sequences were present in at
least 100 independent ESTs. All alternative or pseudo-
exon sequences and the adjacent constitutive exon
sequences were used as templates for the primer design.
For the selection of adjacent constitutive exons, we used
transcript alignment information from the UC Santa Cruz
genome browser Refseq and spliced-ESTs information
tracks (http://genome.ucsc.edu) to select for exons that
were observed to be constantly incorporated into all
documented spliced transcripts of the gene.
Primer design ofselected candidates
Flanking PCRs were designed with forward and reverse
primers targeted to the constitutive exons, ﬂanking the
alternative cassette exons (Figure 1A). Semi-nested PCRs
were designed speciﬁcally for two rounds of PCRs. In the
ﬁrst round of PCR, an ‘external’ forward primer is
targeted to a 50 upstream canonical exonic sequence and
is used with a reverse primer targeted to the alternative
cassette exon. The second round PCR then uses an
‘internal’ forward primer targeted to an exonic region
between the ‘external’ forward primer and the previously
used reverse exon primer. Figure 2A illustrates the semi-
nested primer design. Primer design for all candidate
exons was done with PRIMER3 software (12), using the
following speciﬁc parameter settings: primer length mini-
mum, 19nt, desired, 25nt and maximum, 32nt; melting
temperature minimum, 648C, desired, 708C and max-
imum, 738C; minimum GC content of 45 and maximum
80; product length, 150–700nt; and preﬁltering of
potentially mispriming sequences with the provided
library of human repeats (See Supplementary Data for
list of all primers used). Primer sequences were ordered
from Integrated DNA Technologies (Coralville, Indiana).
RNA samples
Total RNA samples of Universal Whole Mouse, 11-day,
15-day and 17-day mouse embryo, were obtained from
Biochain (Cat No. R4334566, R1334XI-10, R1334XV-10
and R1334XVII-10, respectively). Total RNA samples
of human liver, colon, stomach, thymus, lung, trachea,
placenta, brain, retina, skeletal muscle, testis and
kidney total RNA were obtained from Clontech
(Cat No. 636506, 636553, 636522, 636512, 636524,
636541, 636527, 636530, 636579, 636534, 636533
and 636529, respectively), while skin, breast, ovary,
pancreas, uterus and prostate total RNA samples were
obtained from BioChain (Cat No. R1234218-50,
R1234086-50, R1234086-50, R1234188-50, R1234274-50
and R1234201-50, respectively). All total RNA samples
were collected by the vendors using isolation by acid
guanidinium thiocyanate-phenol-chloroform extraction
and DNAse I treated. The majority of these tissue RNA
samples match a ranking of tissues exhibiting the most
alternative splicing events per tissue according to a study
of ESTs (13) and were also matched with any tissues
known to express the exons in our test set.
Reverse transcription
Superscript III RT kit (Invitrogen catalog 18080-044) was
used to create cDNA, using three diﬀerent types of
primers: oligo-dT, random hexamer and exon-speciﬁc
reverse primers. The oligo-dT primer is a string of 20
deoxythymidylic acid residues. One RT reaction of each
type was performed using 5mg of RNA for each tissue
analyzed. The RT reaction was done following manufac-
turer’s protocols with the following changes. The con-
centration of the primers for the initial 20ml RT reaction
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a concentration of 2mM, gene-speciﬁc primers added
to a concentration of 2mM for each, and for random
hexamers, 50ng were added as provided by the manu-
facturer. The reaction conditions were as follows: Oligo-
dT priming, 1h and 15min at 508C. Random hexamer
priming, 10min at 258C, then 1h and 15min at 508C.
Gene-speciﬁc RT was done with 1h and 15min at 508C.
After RT, the RNA hydrolyzed with NaOH and then
neutralized with Tris pH8.0. The intact cDNA was then
puriﬁed using the Qiagen PCR clean up kit with a ﬁnal
elution of 30ml. All cDNA stocks were tested for the
presence of RNA polymerase II transcript as a quality
control. For experiments in which a pooling strategy was
utilized, 10-fold dilutions from cDNA stocks were pooled
together to use as templates for PCR.
Flanking PCR reactions
Total of 1ml of pooled cDNA template was used per 25ml
reaction tube. All PCRs were carried out with the Sigma
Jumpstart Taq DNA polymerase kit (Cat D9307) on an
MJ Research PTC-200 (Bio-Rad Laboratories). For the
detection of exons by ﬂanking PCR, a program of 40
cycles of melting (45s at 948C), annealing (30s at 568C),
and extension (1min at 728C) was used. PCR products
were separated in 2% agarose gels supplemented with
ethidium bromide, and the DNA was visualized under a
UV light. To evaluate the sensitivity of ﬂanking PCR,
titration experiments were performed on a subset of
alternative exons (see ‘Results’). In each instance, the
alternative isoform was titrated against the constitutive
form beginning with a one-to-one molar ratio (at 50000
copies each), followed ratios of 1:100, 1:1000 and 1:10000
of alternative to constitutive template. Total of 40 cycles
of PCR were used for these experiments, however, three of
the eight were further tested with 55 and 70 cycles (see
‘Supplementary Data’). Analysis using Phoretix 1D
(Nonlinear Dynamics) facilitated precise multiple-lane
band size determinations for all PCR experiments. PCR
reactions that contained a band within 30 base pairs of the
expected size were selected for cloning and sequencing
reactions.
Semi-nested PCR reactions
For the semi-nested PCR primer approach, a ﬁrst round
program of 25 cycles of melting (45s at 948C), annealing
(30s at 568C) and extension (1min at 728C) was used.
A second round was performed for 30 cycles using the
same program with a 1:100 dilution of ﬁrst round reaction
as the template. PCR products were separated in 2%
agarose gels supplemented with ethidium bromide, DNA
was visualized under a UV light. Analysis using Phoretix
40 cycles of PCR
Predicted
exon
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B Oligo-dT primed RT Random hexamer primed RT
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Figure 1. Flanking PCR is more sensitive at detecting exons using random hexamer primed cDNA templates than with oligo-dT primed templates.
(A) Flanking PCRs were designed with forward and reverse primers targeted to the constitutive exons ﬂanking the alternative cassette exons.
(B) A subset of 12 alternative exons tested with the ﬂanking PCR approach and the two diﬀerent methods of priming RT. The oligo-dT primed
experiment detected four alternative exons (lanes 2,3,4 and 5) in comparison to the random hexamer primed experiment that detected eight
(lanes 2,4,5,7,8,9,10 and 11). DNA ladder   shows 25bp, 50bp, 75bp 100bp, then 50bp increments to 350bp, then 500bp and 766bp. The strongest
band represents 200bp.
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band size determinations for all PCR experiments. PCR
reactions that contained a band within 30 base pairs of the
expected size were selected for cloning and sequencing
reactions.
Cloning andsequencing
Flanking PCR products and semi-nested second round
PCR products of the expected predicted size were ligated
into pGEM-T easy vectors (Promega catalog A1360) and
transformed into High Eﬃciency GC10 chemically com-
petent cells (GeneChoice catalog D-4). Bacterial clones
were plated on LB/X-gal/IPTG agar plates and grown
overnight at 378C. A maximum of 12 colonies were picked
from each plated transformation and used for colony PCR
with standard M13 primers. Total of 2ml of this colony
PCR product was then used as the template for cycle
sequencing using Applied Biotech Inc. BigDye Terminator
Cycle Sequencing Mix (cat 4336917) and then run on an
ABI 3700.
RESULTS
Our objective was to systematically evaluate the ability of
diﬀerent RT and PCR methods to detect alternative exons
from a pooled RNA sample. We designed primers for a
test set of 48 known alternatively spliced cassette exons
from the Alternative Splicing Database (11). We also
designed primers for a ‘negative’ set—a set of 24 ‘pseudo-
exons’ (10) that are unlikely to be spliced. These pseudo-
exons were selected by randomly picking pairs of AG
acceptor and GT donor sites from intronic DNA. We
required that these pseudo-exons preserved the protein-
reading frame, contained no stop codons, and were not
present in the human EST database (see ‘Methods’).
We used these test sets to measure the sensitivity
1st 1st
2nd 2nd
25 cycles
30 cycles
1:100
dilution
Predicted
exon
A
B Oligo-dT RT
200bp
100bp
350bp
Random hexamer RT Exon-specific RT
λ       A1     A2     B1     B2 λ       A1     A2     B1     B2 λ       A1     A2     B1     B2
Figure 2. Semi-nested PCR is more sensitive at detecting exons using exon-speciﬁc primed cDNA templates than with either random hexamer or
oligo-dT primed templates. (A) Semi-nested PCRs were designed speciﬁcally for two rounds of PCRs. Thirty cycles of ﬁrst round of PCR with an
‘external’ forward primer targeted to a 50 upstream canonical exonic sequence and used with a reverse primer targeted to the alternative cassette
exon. Twenty-ﬁve cycles of the second round PCR then uses an ‘internal’ forward primer targeted to an exonic region between the ‘external’ forward
primer and the previously used reverse exon primer. A 1:100 dilution of the ﬁrst round reaction is used as a template for the second round reaction.
(B) Two alternative exons tested with the ﬂanking PCR approach and the two diﬀerent methods RT. A1 and A2 are the ﬁrst and second PCR
reactions for the alternative exon in the ABI1 gene. B1 and B2 are the ﬁrst and second PCR reactions for the alternative exon in the NCOA2 gene
(See supplementary table A for the full list of genes). The expected PCR product sizes for the second round reactions are shown with white
arrowheads, The oligo-dT primed experiment did not detected either of the alternative exons (lanes A2 and B2) in comparison to the random
hexamer primed experiment that detected the second exon (lane B2) and the exon-speciﬁc primed experiment that detected both exons (lanes A2 and
B2). DNA ladder   shows 50bp, 75bp, 100bp, then 50bp increments to 350bp, then 500bp and 766bp. The strongest band represents 200bp.
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ciﬁcity [true negatives/(false negatives+true negatives)]
for diﬀerent validation methodologies.
Comparison of PCR amplification strategies: flanking
PCR versus semi-nested PCR
Flanking PCR is the approach most commonly used to
detect alternative cassette exons from individual cDNA
samples as well as pools of samples (3,6–8). It is usually
designed with forward and reverse primers targeted to the
constitutive exons ﬂanking the alternative cassette exon
(Figure 1A). Another approach that is potentially more
sensitive is a semi-nested PCR where the predicted exon is
targeted by one of the PCR primers (Figure 2A). Semi-
nested PCR involves two rounds of PCR. In the ﬁrst
round of semi-nested PCR, an ‘external’ forward primer is
targeted to a 50 upstream canonical exonic sequence and is
used with a reverse primer targeted to the alternative
cassette exon. The second round of PCR is performed to
remove mispriming events that occur in the ﬁrst round and
uses an ‘internal’ forward primer targeted to an exonic
region between the ‘external’ forward primer and the
previously used reverse exon primer.
Semi-nested PCR and ﬂanking PCR was performed
with primers designed to amplify the cassette exons in our
test set. We pooled total RNA from 18 human tissues (see
‘Methods’) and used two diﬀerent types of RT priming
(oligo-dT and random hexamer) followed by PCR. The
reaction products were analyzed by gel electrophoresis,
and bands of the correct size ( 30 bases) were veriﬁed by
cloning and sequencing. If a reaction did not produce a
band, produced a band of the wrong size, or produced
a band of the correct size that was not validated by
sequencing, then it was considered a negative. The results
are shown in Table 1. Semi-nested PCR was able to detect
more alternative exons than ﬂanking PCR, regardless of
which RT priming method was used. For example,
ﬂanking PCR was only able to detect 7/48 (sensi-
tivity=14.6%) exons in our test set with oligo-dT
priming, but semi-nested PCR was able to detect 29/48
(sensitivity=60.4%) under the same conditions. Thus, we
conclude that semi-nested PCR is signiﬁcantly more
sensitive that ﬂanking PCR.
Because the semi-nested PCR approach is so sensitive, a
valid concern is that this approach might detect extremely
rare splicing events in which pseudo-exons are spliced into
transcripts due to errors by the splicing machinery
(splicing ‘noise’). This would lead to the detection of
splicing events that may not be biologically meaningful.
To test this hypothesis, we performed semi-nested PCR on
our negative test set of 24 pseudo-exons. We detected no
alternative splicing events. In fact, we observed no PCR
products of the expected size. Five of our reactions yielded
products that were signiﬁcantly larger than the expected
size and thus did not pass our criteria to be advanced to
the cloning and sequencing reactions (even so, we decided
to sequence these bands and determined that they were
result of mispriming in the PCR reaction) Thus, the semi-
nested PCR approach did not pick up any splicing noise,
indicating that this approach has high speciﬁcity (zero
false positives in our test set).
Comparison of priming strategies for reversetranscription
The results shown in Table 1 and Figure 1B demonstrate
that random hexamer priming of the RT reaction
performs signiﬁcantly better than oligo-dT priming
(although random priming was not superior for every
alternative exon that we tested—see, e.g., lane 3 in
Figure 1B). We hypothesized that this diﬀerence in
sensitivity was the result of incomplete ﬁrst strand
synthesis by the reverse transcriptase. Therefore, to
further improve the sensitivity of our method, we used a
pool of gene-speciﬁc primers in the RT reaction followed
by semi-nested PCR. A total of 72 primers (48 from the
positive test set and 24 from the negative test set) that
hybridize to the constitutive exon immediately 30 of the
cassette exons were used to prime the RT reaction. The
combination of gene-speciﬁc priming of the RT reaction
followed by semi-nested PCR detected 47/48 (98%) of the
cassette exons, an improvement over random-hexamer
priming (42/48) and oligo-dT priming (29/48). The
speciﬁcity of the method was unchanged; zero exons
were ampliﬁed from our negative test set (0/24). We
conclude that the optimal way to prime RT reactions is to
use a pool of gene-speciﬁc primers that are proximal to the
predicted exon.
Flanking PCR islimited by themolecular ratio
ofconstitutive vs alternative splice form
Flanking PCR is widely used for the validation of
predicted cassette exons, and so we sought to better
understand why this method displays such low sensitivity
in our experiments. Therefore, we designed an experiment
where we could precisely control the relative concentra-
tions of the constitutive and alternative splice forms
(see ‘Supplementary Data’). We cloned 16 diﬀerent
cDNA—the constitutive and alternative form for eight
members of our test set. We then mixed diﬀerent ratios of
the alternative and constitutive splice forms and per-
formed ﬂanking PCR to determine the point at which the
Table 1. Detection of 48 alternative cassette exons from a pool of cDNAs by diﬀerent RT-PCR methods
Method of PCR Flanking PCR Semi-nested PCR
Method of RT priming Oligo-dT Random hexamer Oligo-dT Random hexamer Exon speciﬁc
Number of alternatives detected 7/48 (14.6%) 20/48 (41.7%) 29/48 (60.4%) 42/48 (87.5%) 47/48 (97.9%)
Note: The sensitivity for each method is shown in parentheses.
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began with a one-to-one molar ratio, and then titrated the
concentration of alternative form relative to the constitu-
tive form. We used ratios of 1:1, 1:100, 1:1000 and
1:10000 of alternative to constitutive template. Three
of the experiments are shown in Figure 3A. Of the eight
alternative exons we tested, four could not be detected
beyond a 1:1 dilution of alternative to constitutive by
ﬂanking PCR. In another three instances, the alternative
isoform could not be detected beyond a 1:10 ratio with
the constitutive form. Only one instance demonstrated
detection of the alternative at a 1:100 ratio with the
constitutive form. We were unable to improve the
sensitivity of this method by increasing the number of
PCR cycles or by performing a two-step ampliﬁcation
(see ‘Supplementary Data’).
These results suggest that ﬂanking PCR does not have
suﬃcient sensitivity to detect alternative splicing in pooled
samples, or for that matter, in single tissue samples in
which the alternative form is expressed at lower levels than
the constitutive form. This explains the low sensitivity of
the ﬂanking PCR approach seen previously. In those
experiments, samples from 18 tissues were pooled, so if the
alternative isoform is expressed in a tissue-speciﬁc fashion,
the signal is likely to be undetectable by ﬂanking PCR
due to the levels of constitutive isoform present in the
other tissues.
We next repeated three of the titrations describe above
but performed the PCR with a primer targeted to the
alternative exon. For all three cases, we were able to detect
the alternative isoform at much lower concentrations. In
most cases, we detected the alternative isoform even when
the constitutive form was present at a 10000-fold excess
(Figure 3B). These results suggest that the competition
between the alternative and the constitutive isoforms
severely limits the sensitivity of ﬂanking PCR and that this
limitation can be overcome by designing primers that
target the predicted exon directly.
Semi-nested PCR issensitive enoughto detect alternative
Exons in wholemouse total RNA
The sensitivity of the semi-nested PCR combined with
gene-speciﬁc priming led us to consider the possibility that
it could be used to detect cassette exons using total RNA
isolated from a whole organism. This would be desirable
since there are approximately 200 diﬀerent cell types
present in mammals (14), so pooling RNA prepared
separately from each of these cell types is expensive and
ineﬃcient. We selected 26 alternative exons present in the
mouse EST database, many of which were expressed in
tissues that are not commercially available
(Supplementary Table B). We attempted to detect these
cassette exons by performing a RT with gene-speciﬁc
primers followed by semi-nested PCR. Our input was total
RNA isolated from whole mice at 4 developmental stages
(Adult whole mouse, 11-day, 15-day and 17-day mouse
embryo). Alternative exons were eﬃciently detected in
both adult and pooled-embryo developmental stages with
a total of 25 out of 26 (96%) detected. Interestingly,
almost all of the exons were observed in RNA from both
adult and embryo samples, however there was one exon
captured exclusively from the embryo samples. These
results demonstrate that the combination of RT with
gene-speciﬁc primers followed by semi-nested PCR is
sensitive enough to validate predicted cassette exons in
whole organisms.
Using RNA isolated from a whole organism instead of
individual tissues may allow for the more eﬃcient
discovery of alternative exons. For example, in work
published elsewhere, we tested a set of 384 computational
predictions and found 26 novel human exons using our
most sensitive semi-nested PCR approach (15). These
predictions were tested using pooled-RNA stocks isolated
from 18 human tissues. To see if we could improve upon
this by using RNA isolated directly from a whole
organism, we re-analyzed a subset of these predictions
that were conserved in mouse. This subset contained 93
predictions, 9 of which were detected previously in our
human experiments. By using RNA isolated from a whole
mouse adult and embryos, we were able to detect 37
cassette exons (including all 9 detected in human), a
signiﬁcantly higher validation rate (40% versus 6.7%).
These results suggest that the detection of alternative
splicing events using whole-organism RNA is feasible and
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Figure 3. Flanking PCR is limited to detecting molar ratios of 1:10 to
1:100 of alternative to constitutive templates. Abbreviations: C and A
lanes represent constitutive and alternative template controls.
A titration was done of diﬀerent ratios of the alternative and
constitutive splice forms beginning with a one-to-one molar ratio of
50000 copies each, followed by serial dilutions of 1:100,1:1000 and
1:10000 of alternative to constitutive templates. 40 cycles of PCR were
used for both experiments. (A) Most of the alternative exons could not
be detected beyond a 1:10 dilution of alternative to constitutive when
using ﬂanking PCR. Here, only one case showed that the ﬂanking PCR
was able to detect the alternative in at most a 1:100 molar ratio
(bottom gel). (B) The exon-speciﬁc PCR approach demonstrated the
greatest sensitivity in all three cases, detecting the alternative isoform
even when the constitutive form was present at a 10000-fold excess.
DNA ladder   shows 50bp, 75bp, 100bp, then 50bp increments to
350bp, then 500bp and 766bp. The strongest band represents 200bp.
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to the inclusion of more tissues.
DISCUSSION
The large-scale validation of genome-wide predictions has
been limited by the large number of samples and
conditions that must be tested. To date, there has not
been a systematic analysis of the strengths and weaknesses
of diﬀerent approaches to isoform validation. In this
work, we have quantiﬁed the sensitivity and speciﬁcity of
several protocols for the validation of cassette exons. We
examined three ways of priming the RT reaction—poly-
dT priming, random priming and pooled exon-speciﬁc
priming. We also examined two strategies for PCR
ampliﬁcation—ﬂanking PCR, which uses primers that
hybridize to the constitutive exons ﬂanking the predicted
exon, and a semi-nested PCR with a primer that targets
the predicted exon. While all methods tested were highly
speciﬁc (no method produced a false positive), we
observed large diﬀerences in sensitivity. Surprisingly, the
most commonly used method of validation (oligo-dT
primed RT followed by ﬂanking PCR) displayed the
lowest sensitivity—only 14% of our test set was detected.
This is signiﬁcantly worse than the 97% sensitivity
achieved by the best method tested, which uses a pool of
gene-speciﬁc primers to prime the RT reaction followed by
a semi-nested PCR. The high sensitivity of this method
means that it can be used to detect tissue-speciﬁc cassette
exons in an RNA sample isolated from a whole mouse, a
strategy that allows for all tissues to be sampled in a cost-
eﬀective manner.
The results presented in Table 1 demonstrate that the
method of priming the RT reaction is an important factor
in the quality of the resulting cDNA. We found the best
results were obtained when pooled gene-speciﬁc primer
were used, compared with RT by random hexamer
priming, and then oligo-dT priming. These results indicate
that the processivity of the reverse transcriptase limits the
yield of this reaction and has a large impact on the ability
to detect splice forms. While the low eﬃciency of reverse
transcriptase relative to DNA polymerase has been well
documented (16), it was somewhat surprising that the high
sensitivity of the subsequent PCR step was unable to fully
compensate for diﬀerences in cDNA yield between the
three priming methods.
Our results demonstrate that ﬂanking PCR is not able
to detect the alternative splice form when high levels of the
constitutive form are present—often, a 10-fold molar
excess of the constitutive form prevents the detection of
the alternative form. When pooling tissues, this could be
problematic when an alternative splice form is highly
expressed in a single tissue, and yet the ratio of alternative
to constitutive molecules is less than 1:10 in the pooled
sample. Also, the analysis of a single tissue could be
aﬀected by the low sensitivity of ﬂanking PCR, as most
tissues are comprised of multiple cell types, only one of
which may express a particular isoform. The semi-nested
PCR presented here resolves this issue, as it can detect an
alternative cassette exon even when there is a large
(>10000-fold) excess of the constitutive form. One
caveat of our semi-nested approach is that it only
ampliﬁes the 50 end of alternative exons. However, we
believe than the beneﬁts in detection due to this sensitive
approach far outweigh this caveat, as follow up experi-
ments with the primers designed around the 30 end can be
easily done to completely characterize the exon (15).
There are other tradeoﬀs that should be considered
when choosing between ﬂanking PCR and an exon-
speciﬁc approach. For example, by choosing ﬂanking
primers that are targeted to distant constitutive exons (e.g.
exons 1 and 4), one has the potential to detect a larger
number of splicing events, such as exon skipping events or
mutually exclusive splicing, than would be possible with
the semi-nested approach. Futhermore, the ﬂanking
design provides a nice internal control, as the constitutive
isoform should always be ampliﬁed if the reaction is
working correctly. Finally, the ﬂanking approach can give
a semi-quantitative measurement of the relative abun-
dances of the constitutive to alternative isoforms.
However, if one is using a pool of cDNA from diﬀerent
tissues, as we did in these experiments, then one cannot
expect quantitative results from either approach. Also, the
ability to detect multiple types of splicing events is less
important if one is testing speciﬁc predictions. Therefore,
although the semi-nested approach is not a ﬂexible as the
ﬂanking approach, the greatly improved sensitivity makes
it the method of choice.
We have shown that by combining gene-speciﬁc priming
in the RT with a semi-nested PCR, alternative exons can
be detected with a high sensitivity (96%) from RNA
extracted from a whole mouse. This is a signiﬁcant
improvement over previous methods, since every tissue is
sampled with this approach. With small modiﬁcations, we
believe this approach will also be useful for the detection
of micro-RNAs and other non-coding RNAs since these
are often expressed in cell-type dependent manner.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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